Register - FDA PRO Draft Guidance Webinar Replay

Webinar Replay: “How much do you know about the FDA’s Draft PRO Guidance?”

This interactive Web Seminar that explored various elements of the FDA’s Draft Guidance on Patient Reported Outcomess (PROs) in Clinical Research. During the one hour webinar, the scientific and regulatory experts of PRO Consulting also reviewed the answers to 10 questions often asked by clinical researchers, such as:

  • When are validation activities required?
  • What needs to be included in a cognitive debriefing report?
  • How is a Minimally Important Difference (MID) calculated

Presenter: Chad Gwaltney, Ph.D. - Scientist, PRO Consulting

Register to download the "How much do you know about the FDA's Draft PRO Guidance?", which was designed to help researchers make key decisions about the PRO strategy and instruments for clinical programs and individual trials.

Sign up below for ePRO Pulse™, invivodata's industry newsletter